Is the MRVL transaction attributed directly to Chris Koopmans or to a related entity?

The transaction is attributed to shares held by the Christopher R. Koopmans and Heather J. Koopmans Family Trust. The Form 4 classifies the ownership as indirect, with the nature of ownership labeled “By Trust,” linking the sale to that entity rather than direct personal holdings.

Trust of Marvell (NASDAQ: MRVL) COO sells 10K company shares

Filing Impact

(Very High)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Marvell Technology, Inc. President and COO Chris Koopmans reported an open-market sale of 10,000 shares of common stock on behalf of a family trust. The shares were sold at a weighted average price of $162.76 per share under a pre-arranged Rule 10b5-1 trading plan adopted on January 5, 2026. After this transaction, the Christopher R. Koopmans and Heather J. Koopmans Family Trust continued to hold 209,592 shares of Marvell common stock indirectly.

Insider Trade Summary 10b5-1

Net Seller: 10,000 shares ($1,627,600)

Net Sell 1 txn

Insider Koopmans Chris

Role President and COO

Sold 10,000 shs ($1.63M)

Type	Security	Shares	Price	Value
Sale	Common Stock	10,000	$162.76	$1.63M

Holdings After Transaction: Common Stock — 209,592 shares (Indirect, By Trust)

Footnotes (1)

Sales were made pursuant to a 10b5-1 Plan adopted by the Reporting Person on January 5, 2026. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $159.57 to $164.39, inclusive. The reporting person undertakes to provide Marvell Technology, Inc. ("Marvell"), any security holder of Marvell, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Shares held by the Christopher R. Koopmans and Heather J. Koopmans Family Trust.

Key Figures

Shares sold: 10,000 shares Weighted average sale price: $162.76 per share Shares held after transaction: 209,592 shares +1 more

4 metrics

Shares sold 10,000 shares Open-market sale on May 1, 2026

Weighted average sale price $162.76 per share Common stock sale by family trust

Shares held after transaction 209,592 shares Indirect holdings by family trust following sale

Price range of executions $159.57–$164.39 per share Multiple trades within reported range

Key Terms

Rule 10b5-1 Plan, weighted average price, Family Trust, open-market sale

4 terms

Rule 10b5-1 Plan regulatory

"Sales were made pursuant to a 10b5-1 Plan adopted by the Reporting Person"

A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.

weighted average price financial

"The price reported is a weighted average price. These shares were sold in multiple transactions"

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

Family Trust financial

"Shares held by the Christopher R. Koopmans and Heather J. Koopmans Family Trust"

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Form 4 Insider Transactions: What Each Field Means →

05/04/2026 - 04:04 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Koopmans Chris

(Last)

(First)

(Middle)

5488 MARVELL LANE

(Street)

SANTA CLARA

CALIFORNIA

95054

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Marvell Technology, Inc. [ MRVL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	President and COO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/01/2026		S⁽¹⁾		10,000	D	$162.76⁽²⁾	209,592	I	By Trust⁽³⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Sales were made pursuant to a 10b5-1 Plan adopted by the Reporting Person on January 5, 2026.

2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $159.57 to $164.39, inclusive. The reporting person undertakes to provide Marvell Technology, Inc. ("Marvell"), any security holder of Marvell, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

3. Shares held by the Christopher R. Koopmans and Heather J. Koopmans Family Trust.

Remarks:

	Christopher Koopmans by Blair Walters as Attorney-in-Fact	05/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did MRVL executive Chris Koopmans report?

Chris Koopmans reported an open-market sale of Marvell common stock by a related family trust. The Form 4 shows 10,000 shares sold on May 1, 2026, reflecting a planned disposition rather than a new purchase of MRVL shares.

How many Marvell (MRVL) shares did the Koopmans Family Trust sell?

The Christopher R. Koopmans and Heather J. Koopmans Family Trust sold 10,000 shares of Marvell common stock. This transaction was reported as an indirect sale associated with President and COO Chris Koopmans, and the trust continued to hold a significantly larger remaining position afterward.

At what price were MRVL shares sold in this Form 4 filing?

The reported weighted average sale price was $162.76 per MRVL share. Footnotes explain that multiple trades occurred in a price range from $159.57 to $164.39, and detailed breakdowns for each execution price are available upon request from Marvell or the reporting person.

Was the MRVL insider sale by Chris Koopmans under a Rule 10b5-1 plan?

Yes. The filing states that the sales were made under a Rule 10b5-1 trading plan adopted by the reporting person on January 5, 2026. Such pre-arranged plans allow insiders to systematically sell shares according to preset instructions over time.

How many MRVL shares does the Koopmans Family Trust still hold after the sale?

Following the reported sale, the trust’s indirect holdings totaled 209,592 shares of Marvell common stock. This post-transaction figure shows that the 10,000-share sale represented only a small portion of the overall position associated with Chris Koopmans.